X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (776) 776
lung transplant (568) 568
index medicus (537) 537
male (424) 424
transplantation (415) 415
female (401) 401
lung-transplant recipients (391) 391
middle aged (338) 338
adult (335) 335
respiratory system (331) 331
lung transplantation (297) 297
surgery (273) 273
transplantation of organs, tissues, etc (262) 262
lung transplantation - adverse effects (171) 171
aged (168) 168
retrospective studies (164) 164
immunology (160) 160
organ transplant recipients (158) 158
risk factors (150) 150
bronchiolitis obliterans syndrome (142) 142
recipients (135) 135
adolescent (127) 127
animals (126) 126
treatment outcome (118) 118
health aspects (116) 116
infection (114) 114
cardiac & cardiovascular systems (113) 113
infectious diseases (107) 107
analysis (105) 105
diagnosis (97) 97
transplants & implants (96) 96
heart (95) 95
disease (93) 93
respiratory tract diseases (92) 92
rejection (91) 91
mortality (84) 84
young adult (84) 84
risk-factors (81) 81
lungs (80) 80
pharmacology & pharmacy (79) 79
survival (78) 78
bronchiolitis obliterans (77) 77
bronchoalveolar lavage (77) 77
child (75) 75
critical care medicine (75) 75
cystic fibrosis (75) 75
time factors (69) 69
immunosuppression (68) 68
article (67) 67
bronchiolitis obliterans - etiology (64) 64
heart-lung (64) 64
follow-up studies (62) 62
graft rejection (62) 62
infections (61) 61
lung transplantation - immunology (59) 59
lung-transplant (59) 59
immunosuppressive agents - therapeutic use (58) 58
immunocompromised host (57) 57
prognosis (56) 56
care and treatment (52) 52
therapy (52) 52
cytomegalovirus (51) 51
lung transplantation - methods (51) 51
cystic-fibrosis (50) 50
prospective studies (50) 50
transplant recipients (50) 50
bronchiolitis (49) 49
lung transplantation - mortality (49) 49
research (49) 49
biopsy (48) 48
chronic rejection (48) 48
graft rejection - immunology (48) 48
medical research (48) 48
outcomes (48) 48
survival rate (48) 48
bronchiolitis-obliterans-syndrome (46) 46
obliterative bronchiolitis (46) 46
children (45) 45
lung diseases - surgery (45) 45
management (45) 45
mice (45) 45
voriconazole (45) 45
bronchoscopy (44) 44
epidemiology (44) 44
graft rejection - prevention & control (44) 44
abridged index medicus (43) 43
lung transplant recipients (43) 43
pneumonia (43) 43
transplantation, homologous (43) 43
antifungal agents - therapeutic use (42) 42
incidence (42) 42
medicine & public health (42) 42
medicine, experimental (42) 42
microbiology (42) 42
bronchoalveolar lavage fluid (41) 41
quality-of-life (41) 41
bronchiolitis obliterans - pathology (40) 40
prophylaxis (40) 40
cohort studies (39) 39
virus diseases (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1130) 1130
Spanish (36) 36
French (8) 8
German (4) 4
Japanese (2) 2
Chinese (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 01/2019, Volume 155, Issue 1, pp. 178 - 193
Lung transplant is now an established modality for a broad spectrum of end-stage pulmonary diseases. According to the International Society for Heart and Lung... 
lung transplant | dermatology | transplants
Journal Article
American Journal of Respiratory Cell and Molecular Biology, ISSN 1044-1549, 05/2015, Volume 52, Issue 5, pp. 622 - 633
Acute cellular rejection is a known risk factor for the development of obliterative bronchiolitis, which limits the long-term survival of lung transplant... 
Mouse orthotopic lung transplant | Acute rejection | T-bet | IL-17 | Neutrophils | BRONCHIOLITIS | IFN-GAMMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | CYTOKINE | TRANSPLANTATION | CELL BIOLOGY | mouse orthotopic lung transplant | LINEAGE COMMITMENT | RESPONSES | acute rejection | INTERFERON-GAMMA | INTERLEUKIN-17 | RESPIRATORY SYSTEM | REJECTION | neutrophils | TRANSCRIPTION FACTOR | Chemotaxis, Leukocyte | Interleukin-17 - immunology | Pneumonia - pathology | Pneumonia - prevention & control | Graft Rejection - metabolism | Interferon-gamma - metabolism | Mice, 129 Strain | CD40 Ligand - immunology | Allografts | CD40 Ligand - metabolism | Inflammation Mediators - metabolism | CD8-Positive T-Lymphocytes - metabolism | Pneumonia - immunology | Lung - metabolism | Graft Rejection - pathology | Neutrophils - metabolism | Disease Models, Animal | Inflammation Mediators - immunology | Acute Disease | Lung - pathology | Pneumonia - etiology | T-Box Domain Proteins - deficiency | Graft Rejection - prevention & control | Mice, Inbred C57BL | Neutrophils - immunology | Graft Rejection - etiology | Mice, Transgenic | Lung Transplantation - adverse effects | T-Box Domain Proteins - genetics | T-Box Domain Proteins - metabolism | Antibodies - pharmacology | Interleukin-17 - metabolism | Animals | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Lung - drug effects | Mice, Inbred BALB C | Graft Rejection - immunology | CD8-Positive T-Lymphocytes - immunology | Pneumonia - metabolism | Histocompatibility | Lung - immunology | Original Research
Journal Article
Transplant Infectious Disease, ISSN 1398-2273, 12/2017, Volume 19, Issue 6, pp. e12760 - n/a
BackgroundIt is standard practice to administer prophylactic antibiotics post lung transplantation. However, no studies have evaluated the impact of culture... 
culture‐positive infection | lung transplant | culture | transplantation | 30‐day mortality | antibiotic appropriateness | sensitivities | antibiotics | 30-day mortality | culture-positive infection | INFECTIOUS DISEASES | IMMUNOLOGY | SOLID-ORGAN TRANSPLANT | INFECTIOUS COMPLICATIONS | REJECTION | Humans | Middle Aged | Bacteria - drug effects | Postoperative Complications - prevention & control | Respiratory Tract Infections - prevention & control | Intensive Care Units - statistics & numerical data | Male | Antibiotic Prophylaxis - adverse effects | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Respiratory Tract Infections - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Time Factors | Adult | Female | Bronchoalveolar Lavage Fluid - cytology | Retrospective Studies | Child | Length of Stay - statistics & numerical data | Transplant Recipients - statistics & numerical data | Neutrophils | Antibiotic Prophylaxis - methods | Treatment Outcome | Postoperative Complications - epidemiology | Lung Transplantation - adverse effects | Perioperative Period | Bacteria - isolation & purification | Postoperative Complications - microbiology | Adolescent | Tissue Donors - statistics & numerical data | Bronchoalveolar Lavage - statistics & numerical data | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Transplantation of organs, tissues, etc | Organ transplant recipients | Mortality | Transplants & implants | Syngeneic grafts | Lung transplantation | Bronchus | Cultures | Transplantation | Patients | Respiratory tract | Ischemia | Antibiotics | Bronchoalveolar lavage | Bacteria | Alveoli | Culture
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 06/2014, Volume 14, Issue 6, pp. 1328 - 1333
Journal Article
Journal Article
Journal Article
The Journal of Heart and Lung Transplantation, ISSN 1053-2498, 09/2019
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2010, Volume 10, Issue 8, pp. 521 - 526
Journal Article